Academic Reading — Test 34

Reading passage

For most of human history, profound deafness was regarded as an irreversible condition. The cochlea, a spiral-shaped structure deep within the inner ear, converts the vibrations of sound into electrical signals that travel along the auditory nerve to the brain. When the delicate hair cells inside the cochlea are damaged or absent, this conversion fails, and even the most powerful conventional hearing aid, which merely amplifies sound, can do nothing. The achievement of the Australian researcher Graeme Clark was to bypass these damaged cells entirely, stimulating the auditory nerve directly with electrical pulses so that profoundly deaf people might once again perceive sound. Clark's motivation was deeply personal. His father had suffered from severe deafness throughout his life, and the young Clark witnessed first-hand the isolation that the condition could bring. Trained originally as an ear, nose and throat surgeon, he abandoned a comfortable clinical career in the late 1960s to pursue doctoral research, a decision that many of his colleagues considered reckless. At the time, the prevailing scientific opinion held that electrically stimulating the auditory nerve could never reproduce anything resembling intelligible speech. The frequencies and patterns of human language seemed far too complex to be encoded by crude electrodes, and several respected authorities dismissed the entire idea as a waste of effort. A central obstacle was the anatomy of the cochlea itself. To be effective, an array of electrodes had to be threaded along the cochlea's spiral interior without tearing its fragile internal membranes. For years Clark struggled to design a device flexible enough to follow the tightening curve yet stiff enough to be inserted at all. The solution, according to a well-known account, came to him during a seaside holiday in 1977. Idly playing with a spiral seashell and a blade of grass, he discovered that the grass slid smoothly into the shell when it was graded in stiffness, being flexible at the tip and firmer towards the base. This simple natural model directly inspired the design of the implant's electrode array. The first device was implanted in a patient named Rod Saunders in 1978. Saunders had lost his hearing as an adult following a car accident, which meant he already knew what speech sounded like, an important factor in interpreting the unfamiliar sensations the implant produced. When the device was first switched on, the patient did not hear normal speech; instead he experienced a range of buzzes and tones that the brain had to learn to interpret over many weeks of patient training. Crucially, the implant did not simply make sounds louder. It broke incoming sound into different frequency bands and delivered them to different electrodes positioned along the cochlea, loosely imitating the way a healthy ear separates pitches by location. This principle of place coding became the foundation of all later refinements. Early results were greeted with considerable scepticism, and funding was a constant difficulty. Clark received vital support from the University of Melbourne and, later, from an Australian company that would eventually become known as Cochlear Limited. The company invested in turning his laboratory prototype into a reliable, mass-producible product that could survive for decades inside the human body. The first commercial multi-channel implant received regulatory approval in the United States in 1985, a milestone that transformed the technology from an experimental curiosity into an accepted medical treatment available across much of the world. Perhaps the most significant development was the decision to implant the device in children, including those born deaf who had never heard any sound at all. This proved controversial. Some members of the Deaf community argued that deafness was not a defect to be corrected but a cultural identity with its own rich sign language, and they objected strongly to surgery being performed on infants too young to consent. Supporters countered that the brain's ability to learn to process sound, known as plasticity, declines sharply with age, so implanting a child early gave the best chance of developing spoken language. Today the weight of evidence suggests that very young recipients often achieve remarkable fluency, though the ethical debate has never entirely disappeared. By the early twenty-first century, hundreds of thousands of people around the world had received cochlear implants, and the device is frequently described as the first machine to restore a human sense substantially. Clark himself always insisted that the achievement belonged to a large team of engineers, scientists, surgeons and, above all, the patients who volunteered to test an unproven technology. His persistence in the face of expert discouragement remains a striking example of how a problem dismissed as impossible can yield to patient, interdisciplinary effort.